CHEK2 and breast cancer: Furthermore, it is likely that the presence of pathogenic variants in the CHEK2 gene will impact management options for those in whom detection coincides with the diagnosis of breast cancer, in consideration of targeted chemotherapy and the safety of radiotherapy.